Insider Buying week 02-25-22 Yes, there is now Blood on the Streets

  Curious how well insiders are doing with their buys? Scroll the significant buys of the last year. Figuring out the next move in the market has moved into the realms of multidimensional chess playing with cross-currents upon cross-currents swirling below one another, colliding into one another. Just look at the Fed’s dilemma now trying to tighten monetary policy in the face of a potential global conflict.   Putin has unleashed his single-handed insane determination to change the world order. No one knows where this goes and how it ends. Ultimately this war could trump all news but for now, … Read more

Insider Buying week 12-10-21 Closer Inspection showed the Naked Underbelly

Curious how well insiders are doing with their buys? Click on this link or image above to scroll the significant buys of the last year. Infinite multiples and the greater fool theory are showing cracks in the foundation of relative valuation yet the major indices staged a remarkable comeback up 3.82% while insiders nearly doubled that with the average return up 3.82%. A closer inspection though showed the naked underbelly of this market. Momentum favorites are coming under attack and insiders are making a futile attempt to turn the tide. DocuSign and Paypal insiders are nibbling but this won’t likely … Read more

Yields Collapsed- Stocks Soared Insider Buying week 11-5-21 the Race to the Finish

Curious how well insiders are doing with their buys? Click on this link or image above to scroll the significant buys of the last year. 3 Intel birds, 2 Dow Doves, and Archer Aviation in a Pear Tree, on the fourth day of Christmas my true love sent to me:  The shelves might be bare in some stores this XMAS season but there is nothing short of miraculous how the stock market does nothing but power higher. The performance race to the finish we highlighted two weeks ago is game on.  We’ve got a few names to analyze this week … Read more

The Bold, the Inexplicable and the Good Soldiers- Insider Buying Week 9-17-21

For trade, details click on this link to the trades.  There were quite a few buys last week and it took me longer than usual to update it. Also, I will provide a brief recap of the conversation I had with the Chief Medical Officer, Alexander A. Zukiwski at Casi Pharmaceuticals. Casi is a U.S. NASDAQ-listed biotech selling exclusively to the increasingly affluent Chinese middle class.  CASI is a penny stock that will turn into $dollars if things pan out the way I think. They have one approved revenue-producing product with an exciting pipeline. There is a high probability they … Read more